{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "AutoDock/Vina", "TZDs", "high-throughput computing", "human PPAR\u03b3", "molecular docking", "phenolic compounds", "virtual screening"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26604687", "DateCompleted": {"Year": "2016", "Month": "09", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "11", "Day": "04"}], "ELocationID": ["10.2147/DDDT.S93449"], "Language": ["eng"], "Journal": {"ISSN": "1177-8881", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2015"}}, "Title": "Drug design, development and therapy", "ISOAbbreviation": "Drug Des Devel Ther"}, "ArticleTitle": "In silico approach for the discovery of new PPAR\u03b3 modulators among plant-derived polyphenols.", "Pagination": {"StartPage": "5877", "EndPage": "5895", "MedlinePgn": "5877-95"}, "Abstract": {"AbstractText": ["Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) is a well-characterized member of the PPAR family that is predominantly expressed in adipose tissue and plays a significant role in lipid metabolism, adipogenesis, glucose homeostasis, and insulin sensitization. Full agonists of synthetic thiazolidinediones (TZDs) have been therapeutically used in clinical practice to treat type 2 diabetes for many years. Although it can effectively lower blood glucose levels and improve insulin sensitivity, the administration of TZDs has been associated with severe side effects. Based on recent evidence obtained with plant-derived polyphenols, the present in silico study aimed at finding new selective human PPAR\u03b3 (hPPAR\u03b3) modulators that are able to improve glucose homeostasis with reduced side effects compared with TZDs. Docking experiments have been used to select compounds with strong binding affinity (\u0394G values ranging from -10.0\u00b10.9 to -11.4\u00b10.9 kcal/mol) by docking against the binding site of several X-ray structures of hPPAR\u03b3. These putative modulators present several molecular interactions with the binding site of the protein. Additionally, most of the selected compounds have favorable druggability and good ADMET properties. These results aim to pave the way for further bench-scale analysis for the discovery of new modulators of hPPAR\u03b3 that do not induce any side effects."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular and Cell Biology Institute, Miguel Hern\u00e1ndez University, Elche, Spain."}], "LastName": "Encinar", "ForeName": "Jos\u00e9 Antonio", "Initials": "JA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular and Cell Biology Institute, Miguel Hern\u00e1ndez University, Elche, Spain."}], "LastName": "Fern\u00e1ndez-Ballester", "ForeName": "Gregorio", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physics and Computer Architecture Department, Miguel Hern\u00e1ndez University, Elche, Spain."}], "LastName": "Galiano-Ibarra", "ForeName": "Vicente", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular and Cell Biology Institute, Miguel Hern\u00e1ndez University, Elche, Spain ; CIBER: CB12/03/30038 Physiopathology of Obesity and Nutrition, CIBERobn, Instituto de Salud Carlos III, Palma de Mallorca, Spain."}], "LastName": "Micol", "ForeName": "Vicente", "Initials": "V"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Des Devel Ther", "NlmUniqueID": "101475745", "ISSNLinking": "1177-8881"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "PPAR gamma"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazolidinediones"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "isolation & purification", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "PPAR gamma"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects", "isolation & purification", "pharmacology"], "DescriptorName": "Polyphenols"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Thiazolidinediones"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wang L, Waltenberger B, Pferschy-Wenzig EM, et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a review. Biochem Pharmacol. 2014;92(1):73\u201389.", "ArticleIdList": ["PMC4212005", "25083916"]}, {"Citation": "Yu S, Reddy JK. Transcription coactivators for peroxisome proliferator-activated receptors. Biochim Biophys Acta. 2007;1771(8):936\u2013951.", "ArticleIdList": ["17306620"]}, {"Citation": "Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347(6294):645\u2013650.", "ArticleIdList": ["2129546"]}, {"Citation": "Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992;68(5):879\u2013887.", "ArticleIdList": ["1312391"]}, {"Citation": "Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004;10(4):355\u2013361.", "ArticleIdList": ["15057233"]}, {"Citation": "Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr. 2001;21:193\u2013230.", "ArticleIdList": ["11375435"]}, {"Citation": "Attianese GMPG, Desvergne B. Integrative and systemic approaches for evaluating PPARbeta/delta (PPARD) function. Nucl Recept Signal. 2015;13:e001.", "ArticleIdList": ["PMC4419664", "25945080"]}, {"Citation": "Semple RK, Chatterjee VK, O\u2019Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest. 2006;116(3):581\u2013589.", "ArticleIdList": ["PMC1386124", "16511590"]}, {"Citation": "Higgins LS, Mantzoros CS. The development of INT131 as a selective PPARgamma modulator: approach to a safer insulin sensitizer. PPAR Res. 2008;2008:936906.", "ArticleIdList": ["PMC2522386", "18769500"]}, {"Citation": "Auboeuf D, Rieusset J, Fajas L, et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes. 1997;46(8):1319\u20131327.", "ArticleIdList": ["9231657"]}, {"Citation": "Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007;3(4):e64.", "ArticleIdList": ["PMC1857730", "17465682"]}, {"Citation": "Choi SS, Park J, Choi JH. Revisiting PPARgamma as a target for the treatment of metabolic disorders. BMB Rep. 2014;47(11):599\u2013608.", "ArticleIdList": ["PMC4281338", "25154720"]}, {"Citation": "Elte JW, Blickle JF. Thiazolidinediones for the treatment of type 2 diabetes. Eur J Int Med. 2007;18(1):18\u201325.", "ArticleIdList": ["17223037"]}, {"Citation": "Ahmadian M, Suh JM, Hah N, et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19(5):557\u2013566.", "ArticleIdList": ["PMC3870016", "23652116"]}, {"Citation": "Petersen RK, Christensen KB, Assimopoulou AN, et al. Pharmacophore-driven identification of PPARgamma agonists from natural sources. J Comput Aided Mol Des. 2011;25(2):107\u2013116.", "ArticleIdList": ["21069556"]}, {"Citation": "Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111\u2013129.", "ArticleIdList": ["25614221"]}, {"Citation": "Barrajon-Catalan E, Herranz-Lopez M, Joven J, et al. Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties. Adv Exp Med Biol. 2014;824:141\u2013159.", "ArticleIdList": ["25038998"]}, {"Citation": "Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670\u20133695.", "ArticleIdList": ["PMC3672862", "23428572"]}, {"Citation": "Herranz-Lopez M, Barrajon-Catalan E, Segura-Carretero A, Menendez JA, Joven J, Micol V. Lemon verbena (Lippia citriodora) polyphenols alleviate obesity-related disturbances in hypertrophic adipocytes through AMPK-dependent mechanisms. Phytomedicine. 2015;22(6):605\u2013614.", "ArticleIdList": ["26055125"]}, {"Citation": "Higgins LS, Depaoli AM. Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation. Am J Clin Nutr. 2010;91(1):267S\u2013272S.", "ArticleIdList": ["19906796"]}, {"Citation": "Rothwell JA, Perez-Jimenez J, Neveu V, et al. Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database. 2013;2013:bat070.", "ArticleIdList": ["PMC3792339", "24103452"]}, {"Citation": "Lu K, Han M, Ting HL, Liu Z, Zhang D. Scutellarin from Scutellaria baicalensis suppresses adipogenesis by upregulating PPARalpha in 3T3-L1 cells. J Nat Prod. 2013;76(4):672\u2013678.", "ArticleIdList": ["23521110"]}, {"Citation": "Bottegoni G, Rocchia W, Rueda M, Abagyan R, Cavalli A. Systematic exploitation of multiple receptor conformations for virtual ligand screening. PLoS One. 2011;6(5):e18845.", "ArticleIdList": ["PMC3098722", "21625529"]}, {"Citation": "Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778\u20132786.", "ArticleIdList": ["21919503"]}, {"Citation": "Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M. PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res. 2015;43(W1):W443\u2013W447.", "ArticleIdList": ["PMC4489249", "25873628"]}, {"Citation": "Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009;37:W623\u2013W633.", "ArticleIdList": ["PMC2703903", "19498078"]}, {"Citation": "The PyMOL Molecular Graphics System, Version 1.7.4 Schr\u00f6dinger, LLC [computer program] 2015."}, {"Citation": "Guerois R, Nielsen JE, Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol. 2002;320(2):369\u2013387.", "ArticleIdList": ["12079393"]}, {"Citation": "Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33:W382\u2013W388.", "ArticleIdList": ["PMC1160148", "15980494"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 2010;24(5):417\u2013422.", "ArticleIdList": ["PMC2881210", "20401516"]}, {"Citation": "Cheng F, Li W, Zhou Y, et al. AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52(11):3099\u20133105.", "ArticleIdList": ["23092397"]}, {"Citation": "Furukawa A, Arita T, Fukuzaki T, et al. Substituents at the naphthalene C3 position of (-)-cercosporamide derivatives significantly affect the maximal efficacy as PPARgamma partial agonists. Bioorg Med Chem Lett. 2012;22(3):1348\u20131351.", "ArticleIdList": ["22225641"]}, {"Citation": "Rother K, Preissner R, Goede A, Frommel C. Inhomogeneous molecular density: reference packing densities and distribution of cavities within proteins. Bioinformatics. 2003;19(16):2112\u20132121.", "ArticleIdList": ["14594717"]}, {"Citation": "Mirza MU, Ghori NU, Ikram N, Adil AR, Manzoor S. Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus nonstructural protein 5B inhibitors. Drug Des Devel Ther. 2015;9:1825\u20131841.", "ArticleIdList": ["PMC4383224", "25848219"]}, {"Citation": "Borea PA, Varani K, Gessi S, Gilli P, Dalpiaz A. Receptor binding thermodynamics as a tool for linking drug efficacy and affinity. Farmaco. 1998;53(4):249\u2013254.", "ArticleIdList": ["9658581"]}, {"Citation": "Yuriev E. Challenges and advances in structure-based virtual screening. Future Med Chem. 2014;6(1):5\u20137.", "ArticleIdList": ["24358942"]}, {"Citation": "Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3(11):935\u2013949.", "ArticleIdList": ["15520816"]}, {"Citation": "Ripphausen P, Stumpfe D, Bajorath J. Analysis of structure-based virtual screening studies and characterization of identified active compounds. Future Med Chem. 2012;4(5):603\u2013613.", "ArticleIdList": ["22458680"]}, {"Citation": "Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today. 2004;1(4):337\u2013341.", "ArticleIdList": ["24981612"]}, {"Citation": "Danishuddin M, Khan AU. Structure based virtual screening to discover putative drug candidates: necessary considerations and successful case studies. Methods. 2015;71:135\u2013145.", "ArticleIdList": ["25448480"]}, {"Citation": "Shirai NC, Kikuchi M. Structural flexibility of intrinsically disordered proteins induces stepwise target recognition. J Chem Phys. 2013;139(22):225103.", "ArticleIdList": ["24329095"]}, {"Citation": "Shen J, Cheng F, Xu Y, Li W, Tang Y. Estimation of ADME properties with substructure pattern recognition. J Chem Inf Model. 2010;50(6):1034\u20131041.", "ArticleIdList": ["20578727"]}, {"Citation": "Pham-The H, Gonz\u00e1lez-\u00c1lvarez I, Bermejo M, et al. In silico prediction of Caco-2 Cell permeability by a classification QSAR approach. Mol Inf. 2011;30(4):376\u2013385.", "ArticleIdList": ["27466954"]}, {"Citation": "Wang Z, Chen Y, Liang H, Bender A, Glen RC, Yan A. P-glycoprotein substrate models using support vector machines based on a comprehensive data set. J Chem Inf Model. 2011;51(6):1447\u20131456.", "ArticleIdList": ["21604677"]}, {"Citation": "Chen L, Li Y, Zhao Q, Peng H, Hou T. ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques. Mol Pharm. 2011;8(3):889\u2013900.", "ArticleIdList": ["21413792"]}, {"Citation": "Broccatelli F, Carosati E, Neri A, et al. A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields. J Med Chem. 2011;54(6):1740\u20131751.", "ArticleIdList": ["PMC3069647", "21341745"]}, {"Citation": "Kido Y, Matsson P, Giacomini KM. Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem. 2011;54(13):4548\u20134558.", "ArticleIdList": ["PMC3257218", "21599003"]}, {"Citation": "Carbon-Mangels M, Hutter MC. Selecting relevant descriptors for classification by Bayesian estimates: a comparison with decision trees and support vector machines approaches for disparate data sets. Mol Inf. 2011;30(10):885\u2013895.", "ArticleIdList": ["27468108"]}, {"Citation": "Cheng F, Yu Y, Shen J, et al. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers. J Chem Inf Model. 2011;51(5):996\u20131011.", "ArticleIdList": ["21491913"]}, {"Citation": "Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci. 2001;58(5\u20136):737\u2013747.", "ArticleIdList": ["11437235"]}, {"Citation": "Olsen L, Oostenbrink C, Jorgensen FS. Prediction of cytochrome P450 mediated metabolism. Adv Drug Deliv Rev. 2015;86:61\u201371.", "ArticleIdList": ["25958010"]}, {"Citation": "Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76(3):391\u2013396.", "ArticleIdList": ["17708140"]}, {"Citation": "OSIRIS Property Explorer   [Accessed June 29, 2015].  Available from:  http://www.organic-chemistry.org/prog/peo/"}, {"Citation": "Pedretti A, Villa L, Vistoli G. VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model. 2002;21(1):47\u201349.", "ArticleIdList": ["12413030"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "11", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["26604687", "PMC4639521", "10.2147/DDDT.S93449", "dddt-9-5877"]}}], "PubmedBookArticle": []}